Rifabutin with lopinavir/ritonavir in patients coinfected with tuberculosis and HIV in Burkina Faso
Phase of Trial: Phase IV
Latest Information Update: 05 Mar 2019
Price : $35 *
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Rifabutin (Primary)
- Indications HIV-1 infections; Tuberculosis
- Focus Pharmacokinetics
- Acronyms RIFLOPI
- 10 Sep 2018 Status changed from active, no longer recruiting to recruiting.
- 21 Jul 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 21 Dec 2013 New trial record